- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT03401021
Factors Related to the Intention to Quit Among Male Smokers During Their Wives Pregnancy
Factors Associated With Quit Intention Among Male Smokers Whose Partner Got Pregnant: An Exploration Study
Panoramica dello studio
Descrizione dettagliata
With a globally growing number of smokers, up to about half of men and one tenth of women are becoming smokers and relatively few stopping, especially in Mainland China.
It has been proved that tobacco is responsible for even more deaths and diseases. Smokers have two to three times mortality in middle age among otherwise similar persons who had never smoked. According to the literature review, smoking has been confirmed to be an important risk factor to coronary heart disease, chronic obstructive lung disease, cancer, stroke, peptic ulcer, peripheral vascular disease, and so on. In addition, tobacco can also increase the incidence rate of cancer in lung, oral cavity, naso-, oro- and hypopharynx, nasal cavity et.al, as well as myeloid leukemia, among smokers.
For the male smokers at their reproductive ages, who is preparing to have a baby with their partners, smoking may negatively influence their reproductive capacity. Sufficient studies found that the quantity and duration of smoking, especially the current smoking is positively associated with the risk of erectile dysfunction. Smoking may increase the risk of a higher risk of developing oligospermia, asthenozoospermia and teratozoospermia for man in the reproductive years, which may lead to the inefficiency of fertilization and even give birth to abnormal fetus. Besides, secondhand Smoking (SHS) exposure also have further and longer negative effects on their female partner and their baby born in the future. The non-smoking population is much more sensitive to the nicotine in the passive smoking than smokers. The SHS may increase the risk of respiratory infections, ear problem, immediate adverse effects on cardiovascular system, CHD, lung cancer and so on to adults. For the children, the passive smoking makes children have a higher chance to get severe asthma, slow lung growth. Hence, children and women live with smokers may have a higher risk of premature death and disease. Besides, newborns whose mothers were exposed to secondhand smoking showed significantly lower scores in the habituation cluster and motor system cluster [16], as well as the delay of neurobehavioral development regardless of socio-demographic, obstetric and pediatric factors. Conclusively, smoking has direct and indirect negative effect to male smokers in reproductive ages themselves and their family members.
Based on the official statistic figures in 2010, about one third of people in China were current smokers, and the number of young smokers is increasing [4]. While most current smokers (83.9%) report having no intention to quit smoking (WHO, 2011). On average, between 60% and 70% of Chinese men continue to smoke into middle age, which is different with the western countries. Hence, finding out a solution to decrease the married reproductive male smoking rate is extremely crucial.
Overall awareness of the health hazards of tobacco has improved in the last 15 years in China, but is still relatively poor. Even there were several patterns of propaganda and education applied in China, the efficiency is not very satisfactory. Hence, an effective education intervention that delivery the health hazards of tobacco to male smokers and secondhand smoking to their wives and baby born in the future should be developed and implemented for reproductive male smokers in China.
Cigarette can negatively influence the function of respiratory, urinary and other systems, as well as increase the risk of different types of cancer. Secondhand smoking is harmful to their family members. What's worse, the impact of the reproductive system will further damage their baby born in the future. As the overlooking of the impact of maternal smoking on the fetus, the smoking cessation research for the male smokers who plan to have a baby is absent. For Chinese people, the high prevalence and low quitting rate made this situation much worse. In addition, as the cancel of the one-child policy, lots of couples are planning to give birth to a baby in the future decades compared with the period the policy was valid. Considering the high prevalence of male smoking and upcoming high birth rate in China, more smokers, pregnant, and fetus are under the hazard of tobacco use.
Before applying interventions to help male smokers whose partner got pregnant to quit or reduce cigarette smoking, a study exploring their intention to quit smoking and relevant factors must be implemented.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
-
Hong Kong, Hong Kong
- The University of Hong Kong
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- (1) All participants should be males
- (2) All participants should be aged 18 or above;
- (3) All participants should be married;
- (4) All participants should be smoking at least one cigarette per day averagely during the past 3 months;
- (5) All participants should be able to communicate in Mandarin (including reading Chinese)
Exclusion Criteria:
- Smokers who meet the above criteria but are currently involved in other smoking cessation programs or the pilot study and/or mentally or physically unfit for communication will be excluded.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Crrent Male smokers
Male smokers met the inclusion criteria below will be invited to fill in the questionnaires set, part of them will be invited to attend a semi-structured interview(optional).
|
Participants will be asked to respond to the demographic information sheet, Smoking characteristics sheet, the Fagerstrom Test of Nicotine Dependence, the Transtheoretical Model (TTM) variables, Smoking Self-efficacy Questionnaire (SEQ-12), Family Adaptation, Partnership, Growth, Affection, and Resolve (Family APGAR), and a smoking hazard questionnaire.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Quit intention of smoking
Lasso di tempo: Baseline
|
The level of intention to quit of smoking among male smokers who planning to have a baby with their partners will be measured by b) The Transtheoretical Model (TTM) variables.
The Stage of TTM will be assessed by asking the intention of quitting smoking in the past 6 months with the 6-items, which are Precontemplation, Contemplation, Preparation, Action, Maintenance, and Termination
|
Baseline
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Dipendenza da nicotina
Lasso di tempo: Linea di base
|
Il livello di dipendenza da nicotina dei partecipanti sarà misurato dalla scala Fagerstrom Test of Nicotine Dependence (FTND).
L'FTND è uno strumento standard per valutare l'intensità della dipendenza fisica dalla nicotina. Il test è stato progettato per fornire una misura ordinale della dipendenza da nicotina correlata al fumo di sigaretta.
Contiene sei item che valutano la quantità di sigarette consumate, la compulsione all'uso e la dipendenza.
Nel valutare il test Fagerstrom per la dipendenza da nicotina, gli elementi sì/no vengono valutati da 0 a 1 e gli elementi a scelta multipla da 0 a 3. Gli elementi vengono sommati per ottenere un punteggio totale compreso tra 0 e 10.
Più alto è il punteggio totale di Fagerstrom, più intensa è la dipendenza fisica del paziente dalla nicotina.
|
Linea di base
|
|
Self-efficacy level
Lasso di tempo: Baseline
|
Self-efficacy of participants against tobacco will be assessed by using by the SEQ-12.
The SEQ-12 is categorized into two subscales, namely internal stimuli (6 items) and external stimuli (6 items), with total possible scores ranging from 6 to 30 for both internal stimuli and external stimuli.
Higher scores of the SEQ-12 on both subscales indicate greater self-efficacy to refrain from smoking.
|
Baseline
|
|
Self-awareness of the hazard of smoking
Lasso di tempo: Baseline
|
The self-awareness of the hazard of smoking among the participants will be measured by a self-designed smoking hazard questionnaire list.
The smoking hazard questionnaire lists 14 hazard of smoking and SHS to the pregnant, fetus, health, income, social activity, and so on.
Participants responded to each items using a -10 to 10 rating scale ranging from -10 (most negative influence) to 10 (most positive influence).
|
Baseline
|
|
Family support level
Lasso di tempo: Baseline
|
The family support for smoking cessation will be assessed by using the Family APGAR.
The Family APGAR is a 5-item measure of perceived family support [71].
Participants responded to each item using a 5-point rating scale ranging from 0 (never) to 4 (always).
The standard scoring for the FAPGAR interprets high scores (7-10) as indicating a satisfactory support from family and low scores (0-3) indicating severe dysfunctionality support from the family members.
|
Baseline
|
Collaboratori e investigatori
Sponsor
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- UW17-509
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Smettere di fumare
-
Poitiers University HospitalNon ancora reclutamentoTerapia sostitutiva della nicotina | Professionisti sanitari | Desiderio di Tabacco | Tabacco CessationFrancia
Prove cliniche su Questionnaires set
-
University Hospital, ToulouseCompletatoIpertensione polmonare persistente del neonatoFrancia
-
Texas A&M UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)ReclutamentoMetabolismo del glucosio | Metabolismo degli aminoacidiStati Uniti
-
Bradley HospitalNational Institute of Mental Health (NIMH)CompletatoBassa immersione (dispositivo mobile) | Immersione elevata (display montato sulla testa)Stati Uniti
-
Sheba Medical CenterMedtronicCompletatoDiabete mellito, tipo 1Israele
-
Fujian Shengdi Pharmaceutical Co., Ltd.ReclutamentoIpertrigliceridemia grave con alto rischio di pancreatite acutaCina
-
Medical University of South CarolinaNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletatoIctus | Afasia | Afasia non fluenteStati Uniti
-
University of Central FloridaCompletato
-
Azienda Ospedaliera San Camillo ForlaniniMedtronicCompletatoDiabete | Diabete mellito, tipo 1 | LipoipertrofiaItalia
-
Cook Group IncorporatedTerminato
-
Heinrich-Heine University, DuesseldorfChugai Pharma USA; Terumo BCTCompletatoDonatori Allogenici Sani | Fattore stimolante le colonie di granulociti (G-CSF) mobilizzatoGermania